Transforming Diagnostics: Cutting-Edge Techniques in Laboratory Care

Rapid and accurate diagnostic testing is critical for effective management of infectious and non-infectious diseases, particularly in an era of emerging pathogens and antimicrobial resistance. Traditional methods such as microscopy, culture, and serology continue to serve as valuable tools; however, their limitations in speed and sensitivity have driven the evolution of advanced diagnostic techniques. Recent decades have seen the integration of molecular biology, immunology, proteomics, nanotechnology, and artificial intelligence (AI) into diagnostic platforms. Innovations including polymerase chain reaction (PCR), next-generation sequencing (NGS), CRISPR-based diagnostics, biosensors, and digital pathology are transforming laboratory medicine into a faster, more precise, and patient-centered discipline. These advancements are not only improving turnaround time but also enabling decentralized testing in remote and resource-limited settings, thereby expanding access to high-quality healthcare. Furthermore, rapid diagnostics have been shown to reduce healthcare costs by minimizing unnecessary hospital stays and ensuring timely initiation of targeted therapy. This review highlights key developments in diagnostic technologies, their clinical applications, challenges in global implementation, and future prospects for advancing personalized and precision medicine.

Diagnostic testing, Antimicrobial resistance, Molecular diagnostics, PCR, Precision medicine

1. World Health Organization. (2024). Improving diagnosis for patient safety: Reducing diagnostic [Google Scholar] [Crossref]

2. errors and delays. World Health Organization Technical Report Series. [Google Scholar] [Crossref]

3. Payne M, Holmes E. (2022). Next-Generation Technologies in Clinical Diagnostics. Journal of Clinical Laboratory Science, 35(4), 210–222. [Google Scholar] [Crossref]

4. Patel R. (2021). MALDI-TOF Mass Spectrometry for Clinical Microbiology. Clinical Microbiology Reviews, 34(1): e00055-19. [Google Scholar] [Crossref]

5. Smith J, Brown A. (2020). Emerging Trends in Immunodiagnostics and Point-of-Care Testing. Frontiers in Laboratory Medicine, 2(3), 145–158. [Google Scholar] [Crossref]

6. Potrawa K. (2024). Advancements in diagnostic techniques for infectious diseases: A review. J Med Microb Diagn, 13(2), 451. [Google Scholar] [Crossref]

7. Ting D. S. J., Cairns J., Gopal B. P., Ho C. S. et al. (2021). Risk factors, clinical outcomes, and prognostic factors of bacterial keratitis: The Nottingham Infectious Keratitis Study. Front Med, 8, 715118. [Google Scholar] [Crossref]

8. Hoffman J. J., Dart J. K. G., De S. K., Carnt N. et al. (2022). Comparison of culture, confocal microscopy and PCR in microbial keratitis diagnosis. Eye, 36, 2172–2178. [Google Scholar] [Crossref]

9. Wang Y. E., Tepelus T. C., Vickers L. A., Baghdasaryan E. et al. (2019). Role of in vivo confocal microscopy in the diagnosis of infectious keratitis. Int Ophthalmol, 39, 2865–2874. [Google Scholar] [Crossref]

10. Curro-Tafili K., Verbraak F. D., de Vries R., van Nispen R. M. A. et al. (2024). Diagnosing and monitoring Acanthamoeba keratitis using confocal microscopy. Ophthalmic Physiol Opt, 44, 131–152. [Google Scholar] [Crossref]

11. Zhang Y., Xu X., Wei Z., Cao K., Zhang Z., Liang Q. (2023). The global epidemiology and clinical diagnosis of Acanthamoeba keratitis. Journal of Infection and Public Health, 16(6), 841–852. [Google Scholar] [Crossref]

12. Li S., Bian J., Wang Y., Wang S. et al. (2020). Clinical features and serial changes of Acanthamoeba keratitis: An in vivo confocal microscopy study. Eye, 34, 327–334. [Google Scholar] [Crossref]

13. Wu A. W., Papieva I., McDonald K., Dhingra N. et al. (2024). Getting the diagnosis right: World Patient Safety Day 2024. Learning from diagnostic errors in health care. SAGE Journals. [Google Scholar] [Crossref]

14. Singh H., Schiff G. D., Graber M. L., Onakpoya I. et al. (2016). The global burden of diagnostic errors in primary care. BMJ Quality & Safety, 26(6), 484–494. [Google Scholar] [Crossref]

15. Kruk M. E., Gage A. D., Arsenault C., Jordan K. et al. (2018). Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. The Lancet Global Health, 6(12), e1196–e1205. [Google Scholar] [Crossref]

• Measuring Waste of Patient Time in Health Care at Non-Digitized Hospital: An Observational Study in Bangabandhu Sheikh Mujib Medical University, Bangladesh
• Reaffirming Clinical Confidence in Atorvastatin Therapy: A Digital Outreach Case Study from Tamil Nadu, India
• Clinical Manifestations and Therapeutic Response in a Patient with Hypothyroidism: A Case Report
• Eranda (Ricinus Communis) In Gridhrasi (Sciatica): Classical Rationale, Pharmacology and Clinical Evidence- A Narrative Literature Review
• Magnetotherapy in Pain Management: Mechanisms, Clinical Applications, and Future Perspectives – A Review